Effects of long-term sitagliptin on atherosclerotic parameters in type 2 diabetics with stable CAD
Latest Information Update: 13 May 2015
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Atherosclerosis; Coronary artery disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Jan 2014 New trial record
- 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.